Consensus McKesson Corporation

Stocks

MCK

US58155Q1031

Pharmaceuticals

Market Closed - NYSE 21:00:02 20/10/2026 BST			5-day change	1st Jan Change
1,030.12 ^USD	+1.95%		+7.09%	+25.58%

01:50pm	McKesson Corporation Announces Quarterly Dividend, Payable on January 4, 2027	CI
01:23pm	Cencora to acquire American Oncology Network in $2.4 billion deal	RE

Evolution of the Average Target: McKesson Corporation

Evolution of the Target Price: McKesson Corporation

Changes in Analyst Recommendations: McKesson Corporation

03367fcddbf47.bPlkIU4ERYrzt34geCg2vOHz27_UVxAdUypayh7hp0M.GpIVaA1pINnAxUwRCxl09Y2L7_abHWN0YmljjFmG0QJagTFGAkpo3rHmOw~a892269ed974656bb624334a70b448cc

Analysts' recommendations: McKesson Corporation

10-20	Mizuho Adjusts Price Target on McKesson to $1,020 From $905	MT
10-16	UBS Adjusts McKesson Price Target to $1,200 From $1,080, Maintains Buy Rating	MT
10-12	Baird Adjusts Price Target on McKesson to $1,017 From $1,015	MT
10-07	Leerink Partners Adjusts Price Target on McKesson to $1,070 From $1,030	MT
10-07	Truist Downgrades Option Care Health to Buy From Hold on Heels of Announced Sale to McKesson, CD&R; Adjusts PT to $32.05 From $30	MT
09-14	McKesson Continues to Face Medium-Term Headwinds From Declining Employer Coverage of GLP-1, RBC Says	MT
09-03	Argus Adjusts Price Target on McKesson to $970 From $850, Maintains Buy Rating	MT
08-19	McKesson's Specialty Drug Mix Helps Cushion Pricing Pressure, RBC Says	MT
08-19	RBC Initiates McKesson at Sector Perform With $845 Price Target	MT
08-18	Barclays Raises Price Target on McKesson to $1,000 From $925, Maintains Overweight Rating	MT
08-11	Wells Fargo Adjusts Price Target on McKesson to $933 From $812, Maintains Equalweight Rating	MT
08-06	Mizuho Adjusts Price Target on McKesson to $905 From $885	MT
08-06	TD Cowen Adjusts Price Target on McKesson to $1,006 From $989	MT
08-06	Evercore ISI Adjusts Price Target on McKesson to $1,000 From $860	MT
08-06	Baird Adjusts Price Target on McKesson to $1,015 From $955	MT
08-06	UBS Adjusts Price Target on McKesson to $1,080 From $1,050, Maintains Buy Rating	MT
08-06	BofA Securities Adjusts Price Target on McKesson to $1,050 From $950	MT
07-23	Citigroup Raises McKesson Price Target to $1,000 From $945, Maintains Buy Rating	MT
07-22	Baird Adjusts Price Target on McKesson to $955 From $941, Maintains Outperform Rating	MT
07-21	TD Cowen Adjusts McKesson Price Target to $989 From $1,012, Maintains Buy Rating	MT
07-21	BofA Securities Adjusts McKesson Price Target to $925 From $900	MT
07-14	Leerink Partners Adjusts Price Target on McKesson to $950 From $970, Maintains Outperform Rating	MT
07-07	Evercore ISI Adjusts Price Target on McKesson to $860 From $850	MT
06-10	Barclays Cuts McKesson Price Target to $925 From $1,050, Maintains Overweight Rating	MT
06-05	Argus Adjusts Price Target on McKesson to $850 From $1,050, Maintains Buy Rating	MT

More recommendations

Pharmaceuticals Wholesale

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	MCKESSON CORPORATION					-2.79%
	ELI LILLY AND COMPANY					+3.71%
	JOHNSON & JOHNSON					+7.73%
	ABBVIE INC.					-2.24%
	ROCHE HOLDING AG					-1.52%
	MERCK & CO., INC.					+6.92%
	NOVARTIS AG					-2.21%
	ASTRAZENECA PLC					+24.46%
	AMGEN INC.					-10.02%
	GILEAD SCIENCES, INC.					+2.33%
	Average					+2.64%
	Weighted average by Cap.					+3.24%